NCT05995873 2024-03-26
A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
MindLight, LLC
Phase NA Unknown
Clinical Trials
148 trialsNCT05284825 2024-02-15
A Phase II Trial of Intermediate Radiation Dose For Lymphoma
Sunnybrook Health Sciences Centre
Phase NA Unknown
NCT05450146 2024-01-23
Trial-based Effectiveness and Cost-effectiveness of the Partner in Balance Intervention
Maastricht University
Phase NA Unknown
NCT01827605 2023-12-14
A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Fondazione Italiana Linfomi - ETS
Phase 3 Unknown
NCT03341520 2023-11-30
GAZAI
Heidelberg University
Phase 2 Unknown
NCT04089215 2023-11-24
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 2 Unknown
NCT06131268 2023-11-14
RONIN
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase 4 Unknown
NCT06120686 2023-11-07
Biofeedback Training's Impact on Cognitive and Motor Skills in Kids With Intellectual Disabilities
University of Rzeszow
Phase NA Unknown
NCT05165186 2023-10-19
Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions
Massachusetts General Hospital
Phase NA Unknown
NCT05020392 2023-07-25
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3 Unknown
NCT05855395 2023-07-12
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Huashan Hospital
Phase NA Unknown
NCT04763083 2023-07-07
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
NovalGen Ltd.
Phase 1 Unknown
NCT05343611 2023-06-23
Choko-AGE
Universita di Verona
Phase NA Unknown
NCT05902832 2023-06-15
Computer-Mediated Intervention to Enhance Emotional Competence in Children With Autism in Schools
Bar-Ilan University, Israel
Phase NA Unknown
NCT05073250 2023-05-12
IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.
Chinese PLA General Hospital
Phase 2 Unknown
NCT03727334 2023-05-09
m-sTBI
University of British Columbia
Phase NA Unknown
NCT05633095 2023-03-24
The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia
Deepsonbio
Phase NA Unknown
NCT04680117 2022-10-31
SevAsthma
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT05479136 2022-10-27
DRARCH
St. Joseph's Hospital and Medical Center, Phoenix
Phase 3 Unknown
NCT05537506 2022-09-13
Evaluation of Effects of Bracket's Slot System on the Quantity and Quality of Teeth Movements During Orthodontic Leveling and Alignment Stage
Al-Azhar University
Phase NA Unknown
NCT05444322 2022-07-11
A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Zhejiang University
Phase EARLY_PHASE1 Unknown
NCT05328804 2022-04-26
Herombopag + rhTPO in Severe Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT05003141 2022-03-28
PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Phase 1 Unknown
NCT04828434 2022-03-25
V-iCST
University College, London
Phase NA Unknown
NCT04989621 2022-03-24
Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)
Sun Yat-sen University
Phase 2 Unknown
NCT05167929 2022-03-09
Self-determination Enhancement Group for Adults With Mild Intellectual Disability and Their Caregivers in Hong Kong
Chinese University of Hong Kong
Phase NA Unknown
NCT05029349 2022-01-28
VOC-BPCO
Hopital Foch
Phase NA Unknown
NCT03720457 2021-08-31
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma.
Hrain Biotechnology Co., Ltd.
Phase 1 Unknown
NCT03661034 2021-08-24
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
Cognito Therapeutics, Inc.
Phase NA Unknown
NCT05018988 2021-08-24
DVinCHI
University of Ulster
Phase NA Unknown
NCT00003337 2021-08-16
Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 3 Unknown
NCT00003338 2021-08-16
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Gilead Sciences
Phase 2/3 Unknown
NCT04850664 2021-08-06
CBOT-OUD
Evon Medics LLC
Phase 2 Unknown
NCT04982042 2021-08-04
COVID19REHAB
Centro Universitário de Anapolis
Phase NA Unknown
NCT04934930 2021-06-22
FLMRD
Meir Medical Center
Phase 2 Unknown
NCT04873414 2021-06-02
PlaSenTer
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Phase 2/3 Unknown
NCT00317096 2021-05-07
FCM Versus R-FCM Followed by R-Maintenance or Observation Only
Ludwig-Maximilians - University of Munich
Phase 3 Unknown
NCT04842318 2021-04-13
Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study
Ruijin Hospital
Phase 4 Unknown
NCT04767308 2021-02-23
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies
Huazhong University of Science and Technology
Phase EARLY_PHASE1 Unknown
NCT04431089 2021-01-28
Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 2 Unknown
NCT04707079 2021-01-13
A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT03921879 2020-10-23
Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma
Oncotartis, Inc.
Phase 1 Unknown
NCT04324879 2020-07-01
A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Unknown
NCT04370405 2020-05-11
A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 2 Unknown
NCT04379167 2020-05-07
A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 2 Unknown
NCT04323059 2020-03-30
Effectiveness, Tolerability and Safety of Three Formulations in Underfives With Moderate Acute Malnutrition
University of Uyo Teaching Hospital
Phase 4 Unknown
NCT03600363 2020-03-11
A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients
Ruijin Hospital
Phase 2 Unknown
NCT03003559 2020-01-18
HFNC vs Nasal Cannula in Mild Chronic Obstructive Pulmonary Disease Exacerbation
China-Japan Friendship Hospital
Phase NA Unknown
NCT03014869 2020-01-18
High Flow Nasal Cannula vs NPPV in Moderate Chronic Obstructive Pulmonary Disease Exacerbation
China-Japan Friendship Hospital
Phase NA Unknown
NCT04184414 2019-12-03
The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown